Additional Expenditures. In the event that the scope, scale or direction of the Research Collaboration as described in the draft Overall Research Plan attached hereto as EXHIBIT A1 changes after the Effective Date, any additional expenditures required to be made by GTC to support the Research Collaboration shall be funded by SC. All changes in the scope, scale or direction of the Research Collaboration which may trigger additional funding by SC shall be approved in advance by the Joint Research Committee. If such * Confidential information omitted and filed separately with the Commission additional payments relate to items of capital equipment or Third Party software which are reasonably anticipated to be used by GTC to a greater extent outside the Research Collaboration than within the Research Collaboration, then GTC and SC shall negotiate in good faith regarding the allocation of such costs between GTC and SC; provided, however, that GTC cannot not be required to contribute to such costs without its consent. Any payments which become due under this Subsection shall be made in United States dollars quarterly in advance by certified or bank check or wire transfer.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Genome Therapeutics Corp), Collaboration and License Agreement (Genome Therapeutics Corp)